# Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.

> **NCT00140088** · PHASE3 · COMPLETED · sponsor: **AlgoRx Pharmaceuticals** · enrollment: 504 (—)

## Conditions studied

- Procedural Pain

## Interventions

- **DRUG:** ALGRX 3268

## Key facts

- **NCT ID:** NCT00140088
- **Lead sponsor:** AlgoRx Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 504 (—)
- **Last updated:** 2005-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140088, "Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00140088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*